发明名称 |
METHODS AND COMPOSITIONS FOR INCREASING IDURONATE 2-SULFATASE ACTIVITY IN THE CNS |
摘要 |
Provided herein are methods and compositions for treating a subject suffering from a deficiency in iduronate 2-sulfatase in the CNS. The methods include systemic administration of a bifunctional fusion antibody comprising an antibody that crosses the blood brain barrier (BBB) and an iduronate 2-sulfatase. |
申请公布号 |
US2015004160(A1) |
申请公布日期 |
2015.01.01 |
申请号 |
US201414305402 |
申请日期 |
2014.06.16 |
申请人 |
ArmaGen Technologies, Inc. |
发明人 |
Pardridge William M.;Boado Ruben J. |
分类号 |
C07K16/18;C12N9/16 |
主分类号 |
C07K16/18 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating an iduronate-2-sulfatase deficiency in the central nervous system of a subject in need thereof, comprising systemically administering to the subject a therapeutically effective dose of a fusion antibody having iduronate-2-sulfatase activity, wherein the fusion antibody comprises:
(a) a fusion protein comprising the amino acid sequences of an immunoglobulin heavy chain and an iduronate-2-sulfatase, wherein the amino acid sequence of the iduronate-2-sulfatase is covalently linked to the carboxy terminus of the amino acid sequence of the immunoglobulin heavy chain; and (b) an immunoglobulin light chain; wherein the fusion antibody crosses the blood brain barrier (BBB) and catalyzes hydrolysis of 2-sulfate groups of the L-iduronate 2-sulfate units of dermatan sulfate, heparan sulfate or heparin. |
地址 |
Calabasas CA US |